Myelodysplasia News and Research

RSS
Researchers identify frequent SF3B1 gene mutation in myelodysplasia

Researchers identify frequent SF3B1 gene mutation in myelodysplasia

Researchers discover new genetic defect that predisposes people to leukemia, myelodysplasia

Researchers discover new genetic defect that predisposes people to leukemia, myelodysplasia

Jefferson's two-step bone marrow transplant procedure holds promise for cancer patients

Jefferson's two-step bone marrow transplant procedure holds promise for cancer patients

Tosedostat and OPAXIO study results to be presented at ASCO Annual Meeting

Tosedostat and OPAXIO study results to be presented at ASCO Annual Meeting

Cellerant commences CLT-008 Phase I/II trial in patients with leukemia

Cellerant commences CLT-008 Phase I/II trial in patients with leukemia

Oncologists to discuss treatment of blood cancer in elderly

Oncologists to discuss treatment of blood cancer in elderly

Quebec reimburses VIDAZA for treatment of blood cancer

Quebec reimburses VIDAZA for treatment of blood cancer

SAGE launches two new journals in Drug Safety, Hematology

SAGE launches two new journals in Drug Safety, Hematology

NCF announces formal disease model for Chronic Fatigue Syndrome

NCF announces formal disease model for Chronic Fatigue Syndrome

Sanofi-aventis receives FDA approval for new Taxotere Injection Concentrate formulation

Sanofi-aventis receives FDA approval for new Taxotere Injection Concentrate formulation

New research project to discover origin of myelodysplasia

New research project to discover origin of myelodysplasia

Research team confirms gene mutation associated with serious forms of leukaemia

Research team confirms gene mutation associated with serious forms of leukaemia

Spectrum Pharmaceuticals to present clinical data on belinostat at ASCO 2010

Spectrum Pharmaceuticals to present clinical data on belinostat at ASCO 2010

Vion Pharmaceuticals files for bankruptcy

Vion Pharmaceuticals files for bankruptcy

Combined therapy for acute leukemia shows promising results

Combined therapy for acute leukemia shows promising results

Discovery of new syndrome associated with severe congenital neutropenia

Discovery of new syndrome associated with severe congenital neutropenia

FDA accepts Zevalin supplemental biologics license application

FDA accepts Zevalin supplemental biologics license application

FDA approves GSK's Promacta (Eltrombopag)

FDA approves GSK's Promacta (Eltrombopag)

FDA approves Nplate (romiplostim), first bone marrow stimulator for chronic immune thrombocytopenic purpura

FDA approves Nplate (romiplostim), first bone marrow stimulator for chronic immune thrombocytopenic purpura

Genetic mutations and cellular modifications may provide clues to the associations between slight genetic abnormalities and often fatal diseases

Genetic mutations and cellular modifications may provide clues to the associations between slight genetic abnormalities and often fatal diseases